Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu Lato
Key facts
- Who runs it
- University Medical Centre Ljubljana
- Where
- Slovenia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 15,000 people enrolled
- Started
- 31 Dec 2024
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Record updated
- 21 February 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Diagnosis of definitive Lyme borreliosis
Who cannot take part
- /
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Data on reinfections with B. burgdorferi sensu lato in humans are scarce; they are limited to case reports and a few small groups of patients, mostly from the USA and less frequently from Europe. In these reports, the clinical manifestation of reinfection was usually erythema migrans and was most often documented after successful treatment of a previous infection (almost always erythema migrans). The clinical manifestations of Lyme disease in reinfection appear to be similar to those of primary infection, but there are no studies on possible differences in serological or immunological responses.
Read full original descriptionShow less
The current study has 3 primary objectives:
* To determine the frequency of clinically detectable reinfections and to identify the circumstances under which they occur; * To determine possible differences between primary and reinfection in clinical presentation, disease course and outcome, and specific serum antibody response; * To determine the aetiology of clinically detectable reinfections by comparing Borrelia isolates recovered from the skin of the same patient at primary and reinfection.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Publications
- Record updated
- 21 February 2025